Review Article
High-Intensity Focused Ultrasound Treatment for Advanced Pancreatic Cancer
Table 5
Statistical summary of immune factors before and after HIFU ablation in pancreatic cancer patients.
| | | Pre-HIFU | Post-HIFU | Increase |
| | CD3+ () | 37.39 ± 11.78~60.3 ± 5.9 | 51.8 ± 6.4~59.6 ± 6.7 | 112.94% | | CD4+ () | 24.19 ± 7.02~32.6 ± 5.4 | 28 ± 10~34.7 ± 5.3 | 108.89% | | CD4+/CD8+ () | 0.9 ± 0.3~1.1 ± 0.1 | 1.09 ± 0.53~1.4 ± 0.1 | 125.9% | | NK () | 20.54 ± 9.1~21 ± 9 | 25 ± 13~25.52 ± 11.9 | 121.8% |
|
|
